Search - tctmd.com

Displaying 121 - 140 of 630

Sort: Relevancy | Date

EXPLANT-TAVR: Data Spur Conversation About Balancing Risk and Lifetime Management

News Daily News

EXPLANT-TAVR: Data Spur Conversation About Balancing Risk and Lifetime Management

September 22, 2021

Valve-in-Valve TAVI Bests Redo SAVR in Short Term

News Daily News

Valve-in-Valve TAVI Bests Redo SAVR in Short Term

Michael O'Riordan

September 20, 2021

With Some Adjustments, Commissural Alignment Possible With TAVI

News Daily News

With Some Adjustments, Commissural Alignment Possible With TAVI

Michael O'Riordan

September 16, 2021

ENVISAGE-TAVI AF: Edoxaban Disappoints in TAVI Setting

News Conference News ESC 2021

ENVISAGE-TAVI AF: Edoxaban Disappoints in TAVI Setting

August 28, 2021

New TAVI Centers Clustered Together, and Outcomes Suffered: TVT Registry

News Daily News

New TAVI Centers Clustered Together, and Outcomes Suffered: TVT Registry

August 19, 2021

Post-TAVI Pacemaker Rates Down in the US, but ‘Still Quite High’

News Conference News TVT 2021

Post-TAVI Pacemaker Rates Down in the US, but ‘Still Quite High’

July 23, 2021

TAVI Outcomes Similar in Low-Risk Bicuspid, Tricuspid Aortic Stenosis at 1 Year

News Conference News TVT 2021

TAVI Outcomes Similar in Low-Risk Bicuspid, Tricuspid Aortic Stenosis at 1 Year

July 20, 2021

TAVR and SAVR “Sequencing”: Lifelong Management Journey of Severe AS

Presentation TVT 2021

TAVR and SAVR “Sequencing”: Lifelong Management Journey of Severe AS

Presenter: Isaac George

July 20, 2021

Choosing the First TAVR Prosthesis: Self Expanding vs Balloon Expandable – Advantages and Disadvantages

Presentation TVT 2021

Choosing the First TAVR Prosthesis: Self Expanding vs Balloon Expandable – Advantages and Disadvantages

Presenter: Uri Landes

July 20, 2021

Clinical and Anatomic Considerations for TAVR in a Young Patient (<65 yo): Durability, Coronary Access, and More

Presentation TVT 2021

Clinical and Anatomic Considerations for TAVR in a Young Patient (<65 yo): Durability, Coronary Access, and More

Presenter: Gilbert Tang

July 20, 2021

Comparison of 1-Year Outcomes After Transcatheter Aortic Valve Replacement in Low-Risk Patients With Severe Bicuspid and Tricuspid Aortic Valve Stenosis

Presentation TVT 2021

Comparison of 1-Year Outcomes After Transcatheter Aortic Valve Replacement in Low-Risk Patients With Severe Bicuspid and Tricuspid Aortic Valve Stenosis

Presenter: John Forrest

July 20, 2021

Acute MI More Common After TAVI vs SAVR, Real-World Data Suggest

News Daily News

Acute MI More Common After TAVI vs SAVR, Real-World Data Suggest

July 19, 2021

DOACs May Have Advantage Over VKAs After TAVI, Study Hints

News Daily News

DOACs May Have Advantage Over VKAs After TAVI, Study Hints

July 14, 2021

NOTION at 8 Years: TAVI Still Comparable to Surgery

News Daily News

NOTION at 8 Years: TAVI Still Comparable to Surgery

Yael L. Maxwell

July 08, 2021

For TAVI, the Heart Team Approach Is Evolving

News Daily News

Is the Heart Team Concept Waning in TAVI?

Yael L. Maxwell

June 24, 2021

Be ‘Mindful’ of TAVI Unknowns in Younger Patients, Experts Urge

News Daily News

Be ‘Mindful’ of TAVI Unknowns in Younger Patients, Experts Urge

June 09, 2021

Complete 2-Year Data From Evolut Low-Risk Trial ‘Reassuring’ for TAVI

News Conference News EuroPCR 2021

Complete 2-Year Data From Evolut Low-Risk Trial ‘Reassuring’ for TAVI

Yael L. Maxwell

May 19, 2021

ATLANTIS: Apixaban Has No Benefit Over Standard of Care Post-TAVI

News Conference News ACC 2021

ATLANTIS: Apixaban Has No Benefit Over Standard of Care Post-TAVI

Yael L. Maxwell

May 15, 2021

TAVI Beneficial Even in Eldest Patients, Registry Reaffirms

News Daily News

TAVI Beneficial Even in Eldest Patients, Registry Reaffirms

April 19, 2021

Rogers.1-CRT2021.jpg

News Conference News CRT 2021

LRT Trial Data Bolster Support for TAVI in Bicuspid Valves

March 11, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.